1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Namodenoson 25mg: new trials by email Literature Review of Namodenoson 25mg trials Research Report on Namodenoson 25mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Namodenoson Treatment of Advanced Pancreatic Cancer Namodenoson 25mg - Pancreatic Adenocarcinoma, Pancreatic Cancer | Phase 2 | Recruiting | Can-Fite BioPharma | 20 | 2024-11-10 | 2025-01-31 |
Israel (1)
Michael H Silverman, MD (1) · Salomon M Stemmer, MD (1)